Market Insights Health OTC Pharmaceuticals

Skin Treatment - EU-27

EU-27

In the EU-27, the revenue in the Skin Treatment market market reached US$3.11bn in 2024.
According to forecasts, the market is projected to experience an annual growth rate of 5.68% (CAGR 2024-2029).
When compared globally, the in the United States generates the highest revenue, amounting to US$4,184.00m in 2024.
In terms of per capita figures, the revenue generated per person in the EU-27 is US$6.95 in 2024.
In EU-27, the skin treatment market is experiencing a surge in demand for natural and organic products.

Key regions: Australia, Brazil, Canada, China, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Skin Treatment market in EU-27 is experiencing steady growth due to changing customer preferences, emerging trends, and underlying macroeconomic factors.

Customer preferences: Customers in the EU-27 are increasingly prioritizing their skincare routines and investing in skin treatment products. This is driven by a growing awareness of the importance of skincare and the desire to maintain a youthful and healthy appearance. Consumers are seeking products that address specific skin concerns such as aging, acne, and hyperpigmentation. They are also looking for natural and organic ingredients, as well as products that are cruelty-free and environmentally friendly.

Trends in the market: One of the key trends in the Skin Treatment market in EU-27 is the rise of personalized skincare. Customers are seeking customized solutions that cater to their individual skin types and concerns. This has led to the popularity of personalized skincare brands and the use of technology to analyze skin and recommend tailored products.Another trend is the increasing demand for natural and organic skincare products. Consumers are becoming more conscious of the ingredients they put on their skin and are opting for products that are free from harmful chemicals and synthetic fragrances. This has led to the growth of organic and clean beauty brands in the EU-27 market.

Local special circumstances: The EU-27 market is highly regulated when it comes to skincare products. The European Union has strict regulations on the ingredients that can be used in cosmetic products, ensuring the safety and efficacy of skincare products. This has led to a high level of trust among consumers in the EU-27 market, as they know that the products they purchase meet the necessary standards.

Underlying macroeconomic factors: The growing disposable income and changing lifestyles of consumers in the EU-27 are driving the growth of the Skin Treatment market. As people have more money to spend on luxury items, they are willing to invest in high-quality skincare products. Additionally, the increasing focus on self-care and wellness has contributed to the growth of the market, as consumers prioritize taking care of their skin as part of their overall well-being.In conclusion, the Skin Treatment market in EU-27 is experiencing growth due to changing customer preferences, emerging trends, and underlying macroeconomic factors. Customers are seeking personalized and natural skincare solutions, while the strict regulations in the EU-27 market ensure the safety and efficacy of products. The growing disposable income and focus on self-care are also driving the market forward.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.